Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. 

Biotechnology

Arch Therapeutics

Terrence W. Norchi

Shawn Carlson

Evelyn Quintin

Chirag B. Shah

Richard E. Davis

Michael Abrams

The leadership team at Arch Therapeutics has a wealth of experience in the medical technology, finance, and accounting industries. Members of the team have co-founded medical device companies, been free agents at medical technology advisor firms, and held positions such as Chief Financial Officer and Vice President of Research and Development at Innovative Spinal Technologies, Inc. The team also has experience serving on the board of directors for QuantRx Biomedical Corp and FitLife Brands, Inc.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Arch Therapeutics

Board of Directors

CEO and Executive Team